| Saline control | Bevacizumab treatment | ||
---|---|---|---|---|
 | Pre | Post | Pre | Post |
Tumor volume, range (mm3) | 7.34–36.9 | 9.20–58.2 | 6.96–46.8 | 8.13–44.5 |
Tumor volume, mean ± sd (mm3) | 14.7 ± 9.4 | 22.7 ± 15.7 | 16.1 ± 13.2 | 17.8 ± 12.3 |
R1, range (ms–1) | 0.45–0.54 | 0.42–0.55 | 0.45–0.57 | 0.49–0.59 |
R1, mean ± sd (ms–1) | 0.53 ± 0.03 | 0.50 ± 0.04 | 0.53 ± 0.04 | 0.54 ± 0.04 |
Steady-state rCBV, range | 0.76–2.89 | 0.63–1.63 | 0.92–1.61 | 0.63–1.55 |
Steady-state rCBV, mean ± sd | 1.45 ± 0.83 | 1.17 ± 0.45 | 1.20 ± 0.26 | 0.93 ± 0.26 |
Ktrans, range (min–1) | 0.027–0.084 | 0.026–0.084 | 0.016–0.064 | 0.014–0.054 |
Ktrans, mean ± sd (min–1) | 0.047 ± 0.018 | 0.056 ± 0.018 | 0.043 ± 0.016 | 0.031 ± 0.014 |